Richard guy and his collaborators: 'Crackling' the skin code

Skin Pharmacology and Physiology

Volumn 26, Issue 4-6, 2013, Pages 302-312

  Delgado Charro, M B ^a  

^a University of Bath   (United Kingdom)

Author keywords

Dermatopharmacokinetics; Guy, Richard; Iontophoresis; Skin absorption; Topical administration; Transdermal drug delivery

Indexed keywords

BENZOIC ACID; HYDROCORTISONE; TESTOSTERONE;

ARTICLE; BIOAVAILABILITY; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG MECHANISM; ELIMINATION RATE CONSTANT; HUMAN; INFRARED SPECTROSCOPY; IONTOPHORESIS; PRIORITY JOURNAL; SKIN ABSORPTION; SKIN PENETRATION; SKIN PERMEABILITY; URINARY EXCRETION;

ADMINISTRATION, CUTANEOUS; ANIMALS; DIELECTRIC SPECTROSCOPY; DRUG DELIVERY SYSTEMS; HISTORY, 20TH CENTURY; HUMANS; IONTOPHORESIS; MODELS, BIOLOGICAL; NANOPARTICLES; PHARMACEUTICAL PREPARATIONS; SKIN; SKIN ABSORPTION; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 84881420006     PISSN: 16605527     EISSN: 16605535     Source Type: Journal    
DOI: 10.1159/000351937     Document Type: Article

References (134)

1. Scopus author search. http://www.scopus. com/authid/detail.url?authorId=7201580157 (accessed December 20, 2012).
2. Researcher ID. Thomson Reuters. http:// www.researcherid.com/rid/H-3471-2012 (accessed December 20, 2012).
3. Potts RO, Guy RH: Predicting skin permeability. Pharm Res 1992; 9: 663-669.
4. Alvarez-Roman R, Naik A, Kalia Y, Guy RH, Fessi H: Skin penetration and distribution of polymeric nanoparticles. J Control Release 2004; 99: 53-62.
5. Potts RO, Guy RH: A predictive algorithm for skin permeability: the effects of molecular size and hydrogen bond activity. Pharm Res 1995; 12: 1628-1633.
6. Naik A, Pechtold LARM, Potts RO, Guy RH: Mechanism of oleic acid-induced skin penetration enhancement in vivo in humans. J Control Release 1995; 37: 299-306.
7. Bommannan D, Potts RO, Guy RH: Examination of stratum corneum barrier function in vivo by infrared spectroscopy. J Invest Dermatol 1990; 95: 403-408.
8. Delgado-Charro MB, Iglesias-Vilas G, Blanco-Méndez J, López-Quintela MA, Marty J, Guy RH: Delivery of a hydrophilic solute through the skin from novel microemulsion systems. Eur J Pharm Biopharm 1997; 43: 37-42.
9. Kalia YN, Pirot F, Guy RH: Homogeneous transport in a heterogeneous membrane: water diffusion across human stratum corneum in vivo. Biophys J 1996; 71: 2692-2700.
10. Mehier-Humbert S, Bettinger T, Yan F, Guy RH: Plasma membrane poration induced by ultrasound exposure: implication for drug delivery. J Control Release 2005; 104: 213-222.
11. Pirot F, Kalia YN, Stinchcomb AL, Keating G, Bunge A, Guy RH: Characterization of the permeability barrier of human skin in vivo. Proc Natl Acad Sci USA 1997; 94: 1562-1567.
12. Bommannan D, Menon GK, Okuyama H, Elias PM, Guy RH: Sonophoresis. II. Examination of the mechanism(s) of ultrasound-enhanced transdermal drug delivery. Pharm Res 1992; 9: 1043-1047.
13. Gay CL, Guy RH, Golden GM, Mak VHW, Francoeur ML: Characterization of low-temperature (i.e. <65°C) lipid transitions in human stratum corneum. J Invest Dermatol 1994; 103: 233-239.
14. Alvarez-Román R, Naik A, Kalia YN, Guy RH, Fessi H: Enhancement of topical delivery from biodegradable nanoparticles. Pharm Res 2004; 21: 1818-1825.
15. Bommannan D, Potts RO, Guy RH: Examination of the effect of ethanol on human stratum corneum in vivo using infrared spectroscopy. J Control Release 1991; 16: 299-304.
16. Delgado-Charro MB, Guy RH: Characterization of convective solvent flow during iontophoresis. Pharm Res 1994; 11: 929-935.
17. Bommannan D, Okuyama H, Stauffer P, Guy RH: Sonophoresis. I. The use of high-frequency ultrasound to enhance transdermal drug delivery. Pharm Res 1992; 9: 559-564.
18. Marro D, Guy RH, Delgado-Charro MB: Characterization of the iontophoretic permselectivity properties of human and pig skin. J Control Release 2001; 70: 213-217.
19. Kalia YN, Nonato LB, Lund CH, Guy RH: Development of skin barrier function in premature infants. J Invest Dermatol 1998; 111: 320-326.
20. Kim A, Green PG, Rao G, Guy RH: Convective solvent flow across the skin during iontophoresis. Pharm Res 1993; 10: 1315-1320.
21. Marro D, Kalia YN, Delgado-Charro MB, Guy RH: Contributions of electromigration and electroosmosis to iontophoretic drug delivery. Pharm Res 2001; 18: 1701-1708.
22. Rao G, Guy RH, Glikfeld P, LaCourse WR, Leung L, Tamada J, Potts RO, Azimi N: Reverse iontophoresis: noninvasive glucose monitoring in vivo in humans. Pharm Res 1995; 12: 1869-1873.
23. Guy RH, Hadgraft J. Mathematical models in percutaneous absorption; in Maibach HI, Lowe NJ (eds): Models in Dermatology. Basel, Karger, 1985, vol 2, pp 170-177.
24. Guy RH, Hadgraft J: Physicochemical interpretation of the pharmacokinetics of percutaneous absorption. J Pharmacokinet Biopharm 1983; 11: 189-203.
25. Guy RH, Hadgraft J, Maibach HI: A pharmacokinetic model for percutaneous absorption. Int J Pharm 1982; 11: 119-129.
26. Guy RH, Hadgraft J: Prediction of drug disposition kinetics in skin and plasma following topical administration. J Pharm Sci 1984; 73: 883-887.
27. Guy RH, Hadgraft J: Transdermal drug delivery: a simplified pharmacokinetic approach. Int J Pharm 1985; 24: 267-274.
28. Guy RH, Hadgraft J: Pharmacokinetic interpretation of the plasma levels of clonidine following transdermal delivery. J Pharm Sci 1985; 74: 1016-1018.
29. Guy RH, Hadgraft J: The prediction of plasma levels of drugs following transdermal application. J Control Release 1985; 1: 177-182.
30. Evans N, Guy RH, Hadgraft J: Transdermal drug delivery to neonates. Int J Pharm 1985; 24: 259-265.
31. Guy RH, Hadgraft J: Interpretation and prediction of the kinetics of transdermal drug delivery: oestradiol, hyoscine and timolol. Int J Pharm 1986; 32: 159-163.
32. Guy RH, Hadgraft J: A theoretical description relating skin penetration to the thickness of the applied medicament. Int J Pharm 1980; 6: 321-332.
33. Guy RH, Hadgraft J, Kellaway IW, Taylor M: Calculations of drug release rates from particles. Int J Pharm 1982; 11: 199-207.
34. Guy RH, Hadgraft J: Rate control in transdermal drug delivery? Int J Pharm 1992; 82:R1-R6.
35. Guy RH, Hadgraft J: Physicochemical aspects of percutaneous penetration and its enhancement. Pharm Res 1988; 5: 753-758.
36. Green PG, Guy RH, Hadgraft J: In vitro and in vivo enhancement of skin permeation with oleic and lauric acids. Int J Pharm 1988; 48: 103-111.
37. Surber C, Wilhelm KP, Hori M, Maibach HI, Guy RH: Optimization of topical therapy: partitioning of drugs into stratum corneum. Pharm Res 1990; 7: 1320-1324.
38. Potts RO, Mak VH, Guy RH, Francoeur ML: Strategies to enhance permeability via stratum corneum lipid pathways. Adv Lipid Res 1991; 24: 173-210.
39. Mak VHW, Potts RO, Guy RH: Oleic acid concentration and effect in human stratum corneum: non-invasive determination by attenuated total reflectance infrared spectroscopy in vivo. J Control Release 1990; 12: 67-75.
40. Mak VHW, Potts RO, Guy RH: Percutaneous penetration enhancement in vivo measured by attenuated total reflectance infrared spectroscopy. Pharm Res 1990; 7: 835-841.
41. Potts RO, Golden GM, Francoeur ML, Mak VHW, Guy RH: Mechanism and enhancement of solute transport across the stratum corneum. J Control Release 1991; 15: 249-260.
42. Mak VHW, Potts RO, Guy RH: Does hydration affect intercellular lipid organization in the stratum corneum? Pharm Res 1991; 8: 1064-1065.
43. Higo N, Naik A, Bommannan DB, Potts RO, Guy RH: Validation of reflectance infrared spectroscopy as a quantitative method to measure percutaneous absorption in vivo. Pharm Res 1993; 10: 1500-1506.
44. Kalia YN, Alberti I, Sekkat N, Curdy C, Naik A, Guy RH: Normalization of stratum corneum barrier function and transepidermal water loss in vivo. Pharm Res 2000; 17: 1148-1150.
45. Alberti I, Kalia YN, Naik A, Bonny JD, Guy RH: In vivo assessment of enhanced topical delivery of terbinafine to human stratum corneum. J Control Release 2001; 71: 319-327.
46. Alberti I, Kalia YN, Naik A, Bonny JD, Guy RH: Effect of ethanol and isopropyl myristate on the availability of topical terbinafine in human stratum corneum, in vivo. Int J Pharm 2001; 219: 11-19.
47. Alberti I, Kalia YN, Naik A, Guy RH: Assessment and prediction of the cutaneous bioavailability of topical terbinafine, in vivo, in man. Pharm Res 2001; 18: 1472-1475.
48. Herkenne C, Naik A, Kalia YN, Hadgraft J, Guy RH: Ibuprofen transport into and through skin from topical formulations: In vitro-in vivo comparison. J Invest Dermatol 2007; 127: 135-142.
49. Herkenne C, Naik A, Kalia YN, Hadgraft J, Guy RH: Dermatopharmacokinetic prediction of topical drug bioavailability in vivo. J Invest Dermatol 2007; 127: 887-894.
50. Herkenne C, Naik A, Kalia YN, Hadgraft J, Guy RH: Effect of propylene glycol on ibuprofen absorption into human skin in vivo. J Pharm Sci 2008; 97: 185-197.
51. Herkenne C, Naik A, Kalia YN, Hadgraft J, Guy RH: Pig ear skin ex vivo as a model for in vivo dermatopharmacokinetic studies in man. Pharm Res 2006; 23: 1850-1856.
52. Sekkat N, Kalia YN, Guy RH: Biophysical study of porcine ear skin in vitro and its comparison to human skin in vivo. J Pharm Sci 2002; 91: 2376-2381.
53. Reddy MB, Guy RH, Bunge AL: Does epidermal turnover reduce percutaneous penetration? Pharm Res 2000; 17: 1414-1419.
54. Nicoli S, Bunge AL, Delgado-Charro MB, Guy RH: Dermatopharmacokinetics: factors influencing drug clearance from the stratum corneum. Pharm Res 2009; 26: 865-871.
55. Reddy MB, Stinchcomb AL, Guy RH, Bunge AL: Determining dermal absorption parameters in vivo from tape strip data. Pharm Res 2002; 19: 292-298.
56. N'Dri-Stempfer B, Navidi WC, Guy RH, Bunge AL: Improved bioequivalence assessment of topical dermatological drug products using dermatopharmacokinetics. Pharm Res 2009; 26: 316-328.
57. Wiedersberg S, Leopold CS, Guy RH: Dermatopharmacokinetics of betamethasone 17-valerate: influence of formulation viscosity and skin surface cleaning procedure. Eur J Pharm Biopharm 2009; 71: 362-366.
58. Mohammed D, Yang Q, Guy RH, Matts PJ, Hadgraft J, Lane ME: Comparison of gravimetric and spectroscopic approaches to quantify stratum corneum removed by tapestripping. Eur J Pharm Biopharm 2012; 82: 171-174.
59. Russell LM, Guy RH: Novel imaging method to quantify stratum corneum in dermatopharmacokinetic studies. Pharm Res 2012; 29: 2389-2397.
60. Russell LM, Guy RH: Novel imaging method to quantify stratum corneum in dermatopharmacokinetic studies: proof-of-concept with acyclovir formulations. Pharm Res 2012; 29: 3362-3372.
61. Glikfeld P, Cullander C, Hinz RS, Guy RH: A new system for in vitro studies of iontophoresis. Pharm Res 1988; 5: 443-446.
62. Glikfeld P, Hinz RS, Guy RH: Noninvasive sampling of biological fluids by iontophoresis. Pharm Res 1989; 6: 988-990.
63. Rao G, Glikfeld P, Guy RH: Reverse iontophoresis: Development of a noninvasive approach for glucose monitoring. Pharm Res 1993; 10: 1751-1755.
64. Guy RH, Rao G. Glikfeld P, Cullander C, Hinz RS: Method for the iontophoretic non-invasive determination of the in vivo concentration level of glucose. US Patent No 5730714. 1998. http://xrint.com/patents/us.
65. Merino V, López A, Hochstrasser D, Guy RH: Noninvasive sampling of phenylalanine by reverse iontophoresis. J Control Release 1999; 61: 65-69.
66. Sieg A, Guy RH, Delgado-Charro MB: Electroosmosis in transdermal iontophoresis: implications for noninvasive and calibrationfree glucose monitoring. Biophys J 2004; 87: 3344-3350.
67. Sieg A, Guy RH, Delgado-Charro MB: Noninvasive glucose monitoring by reverse iontophoresis in vivo: application of the internal standard concept. Clin Chem 2004; 50: 1383-1390.
68. Sieg A, Guy RH, Delgado-Charro MB: Reverse iontophoresis for noninvasive glucose monitoring: the internal standard concept. J Pharm Sci 2003; 92: 2295-2302.
69. Sieg A, Guy RH, Delgado-Charro MB: Simultaneous extraction of urea and glucose by reverse iontophoresis in vivo. Pharm Res 2004; 21: 1805-1810.
70. Sieg A, Jeanneret F, Fathi M, Hochstrasser D, Rudaz S, Veuthey JL, Guy RH, Delgado-Charro MB: Extraction of amino acids by reverse iontophoresis in vivo. Eur J Pharm Biopharm 2009; 72: 226-231.
71. Sieg A, Jeanneret F, Fathi M, Hochstrasser D, Rudaz S, Veuthey JL, Guy RH, Delgado-Charro MB: Extraction of amino acids by reverse iontophoresis: simulation of therapeutic monitoring in vitro. Eur J Pharm Biopharm 2008; 70: 908-913.
72. Nixon S, Sieg A, Delgado-Charro MB, Guy RH: Reverse iontophoresis of L-lactate: in vitro and in vivo studies. J Pharm Sci 2007; 96: 3457-3465.
73. Leboulanger B, Aubry JM, Bondolfi G, Guy RH, Delgado-Charro MB: Lithium monitoring by reverse iontophoresis in vivo. Clin Chem 2004; 50: 2091-2100.
74. Leboulanger B, Fathi M, Guy RH, Delgado-Charro MB: Reverse iontophoresis as a noninvasive tool for lithium monitoring and pharmacokinetic profiling. Pharm Res 2004; 21: 1214-1222.
75. Leboulanger B, Guy RH, Delgado-Charro MB: Non-invasive monitoring of phenytoin by reverse iontophoresis. Eur J Pharm Sci 2004; 22: 427-433.
76. Delgado-Charro MB, Guy RH: Transdermal reverse iontophoresis of valproate: a noninvasive method for therapeutic drug monitoring. Pharm Res 2003; 20: 1508-1513.
77. Bouissou CC, Sylvestre JP, Guy RH, Delgado-Charro MB: Reverse iontophoresis of amino acids: identification and separation of stratum corneum and subdermal sources in vitro. Pharm Res 2009; 26: 2630-2638.
78. Sekkat N, Naik A, Kalia YN, Glikfeld P, Guy RH: Reverse iontophoretic monitoring in premature neonates: feasibility and potential. J Control Release 2002; 81: 83-89.
79. Sylvestre JP, Bouissou CC, Guy RH, Delgado-Charro MB: Extraction and quantification of amino acids in human stratum corneum in vivo. Br J Dermatol 2010; 163: 458-465.
80. Wascotte V, Delgado-Charro MB, Rozet E, Wallemacq P, Hubert P, Guy RH, Préat V: Monitoring of urea and potassium by reverse iontophoresis in vitro. Pharm Res 2007; 24: 1131-1137.
81. Wascotte V, Rozet E, Salvaterra A, Hubert P, Jadoul M, Guy RH, Préat V: Non-invasive diagnosis and monitoring of chronic kidney disease by reverse iontophoresis of urea in vivo. Eur J Pharm Biopharm 2007; 69: 1077-1082.
82. Wascotte V, Caspers P, De Sterke J, Jadoul M, Guy RH, Préat V: Assessment of the 'skin reservoir' of urea by confocal Raman microspectroscopy and reverse iontophoresis in vivo. Pharm Res 2007; 24: 1897-1901.
83. Yang Q: Application of Biophysics and Bioengineering to the Assessment of Skin Barrier Function; PhD thesis, University of Bath, 2011
84. Green P, Shroot B, Bernerd F, Pilgrim WR, Guy RH: In vitro and in vivo iontophoresis of a tripeptide across nude rat skin. J Control Release 1992; 20: 209-218.
85. Green PG, Hinz RS, Cullander C, Yamane G, Guy RH: Iontophoretic delivery of amino acids and amino acid derivatives across the skin in vitro. Pharm Res 1991; 8: 1113-1120.
86. Green PG, Hinz RS, Kim A, Cullander C, Yamane G, Szoka FC, Guy RH: Transdermal iontophoresis of amino acids and peptides in vitro. J Control Release 1992; 21: 187-190.
87. Green PG, Hinz RS, Szoka FC, Guy RH: Iontophoretic delivery of a series of tripeptides across the skin in vitro. Pharm Res 1991; 8: 1121-1127.
88. Langkjær L, Brange J, Grodsky GM, Guy RH: Iontophoresis of monomeric insulin analogues in vitro: effects of insulin charge and skin pretreatment. J Control Release 1998; 51: 47-56.
89. Delgado-Charro MB, Guy RH: Characterization of convective solvent flow during iontophoresis. Pharm Res 1994; 11: 929-935.
90. Delgado-Charro MB, Guy RH: Iontophoretic delivery of nafarelin across the skin. Int J Pharm 1995; 117: 165-172.
91. Hirvonen J, Guy RH: Transdermal iontophoresis: modulation of electroosmosis by polypeptides. J Control Release 1998; 50: 283-289.
92. Hirvonen J, Kalia YN, Guy RH: Transdermal delivery of peptides by iontophoresis. Nat Biotechnol 1996; 14: 1710-1713.
93. Santi P, Guy RH: Reverse iontophoresis-parameters determining electroosmotic flow. I. pH and ionic strength. J Control Release 1996; 38: 159-165.
94. Santi P, Guy RH: Reverse iontophoresis: parameters determining electro-osmotic flow. II. Electrode chamber formulation. J Control Release 1996; 42: 29-36.
95. Hirvonen J, Guy RH: Iontophoretic delivery across the skin: electroosmosis and its modulation by drug substances. Pharm Res 1997; 14: 1258-1263.
96. Turner NG, Ferry L, Price M, Cullander C, Guy RH: Iontophoresis of poly-L-lysines: the role of molecular weight? Pharm Res 1997; 14: 1322-1331.
97. Turner NG, Guy RH: Iontophoretic transport pathways: dependence on penetrant physicochemical properties. J Pharm Sci 1997; 86: 1385-1389.
98. Turner NG, Guy RH: Visualization and quantitation of iontophoretic pathways using confocal microscopy. J Invest Dermatol Symp Proc 1998; 3: 136-142.
99. Oh SY, Guy RH: Effects of iontophoresis on the electrical properties of human skin in vivo. Int J Pharm 1995; 124: 137-142.
100. Oh SY, Leung L, Bommannan D, Guy RH, Potts RO: Effect of current, ionic strength and temperature on the electrical properties of skin. J Control Release 1993; 27: 115-125.
101. Kalia YN, Guy RH: The electrical characteristics of human skin in vivo. Pharm Res 1995; 12: 1605-1613.
102. Kalia YN, Nonato LB, Guy RH: The effect of iontophoresis on skin barrier integrity: noninvasive evaluation by impedance spectroscopy and transepidermal water loss. Pharm Res 1996; 13: 957-960.
103. Kalia YN, Guy RH: Interaction between penetration enhancers and iontophoresis: effect on human skin impedance in vivo. J Control Release 1997; 44: 33-42.
104. Kalia YN, Nonato LB, Lund CH, Guy RH: Development of skin barrier function in premature infants. J Invest Dermatol 1998; 111: 320-326.
105. Marro D, Kalia YN, Delgado-Charro MB, Guy RH: Optimizing iontophoretic drug delivery: Identification and distribution of the charge-carrying species. Pharm Res 2001; 18: 1709-1713.
106. Merino V, López A, Kalia YN, Guy RH: Electrorepulsion versus electroosmosis: effect of pH on the iontophoretic flux of 5-fluorouracil. Pharm Res 1999; 16: 758-761.
107. Lopez RFV, Bentley MVLB, Delgado-Charro MB, Guy RH: Iontophoretic delivery of 5-aminolevulinic acid (ALA): effect of pH. Pharm Res 2001; 18: 311-315.
108. Lopez RFV, Bentley MVLB, Delgado-Charro MB, Guy RH: Optimization of aminolevulinic acid delivery by iontophoresis. J Control Release 2003; 88: 65-70.
109. Lopez RFV, Bentley MVLB, Delgado-Charro MB, Salomon D, Van Den Bergh H, Lange N, Guy RH: Enhanced delivery of 5-aminolevulinic acid esters by iontophoresis in vitro. Photochem Photobiol 2003; 77: 304-308.
110. Mudry B, Carrupt PA, Guy RH, Delgado-Charro MB: Quantitative structure-permeation relationship for iontophoretic transport across the skin. J Control Release 2007; 122: 165-172.
111. Mudry B, Guy RH, Delgado-Charro MB: Prediction of iontophoretic transport across the skin. J Control Release 2006; 111: 362-367.
112. Mudry B, Guy RH, Delgado-Charro MB: Electromigration of ions across the skin: Determination and prediction of transport numbers. J Pharm Sci 2006; 95: 561-569.
113. Mudry B, Guy RH, Delgado-Charro MB: Transport numbers in transdermal iontophoresis. Biophys J 2006; 90: 2822-2830.
114. Schuetz YB, Carrupt PA, Naik A, Guy RH, Kalia YN: Structure-permeation relationships for the non-invasive transdermal delivery of cationic peptides by iontophoresis. Eur J Pharm Sci 2006; 29: 53-59.
115. Schuetz YB, Naik A, Guy RH, Kalia YN: Effect of amino acid sequence on transdermal iontophoretic peptide delivery. Eur J Pharm Sci 2005; 26: 429-437.
116. Schuetz YB, Naik A, Guy RH, Vuaridel E, Kalia YN: Transdermal iontophoretic delivery of triptorelin in vitro. J Pharm Sci 2005; 94: 2175-2182.
117. Schuetz YB, Naik A, Guy RH, Vuaridel E, Kalia YN: Transdermal iontophoretic delivery of vapreotide acetate across porcine skin in vitro. Pharm Res 2005; 22: 1305-1312.
118. Abla N, Geiser L, Mirgaldi M, Naik A, Veuthey JL, Guy RH, Kalia YN: Capillary zone electrophoresis for the estimation of transdermal iontophoretic mobility. J Pharm Sci 2005; 94: 2667-2675.
119. Abla N, Naik A, Guy RH, Kalia YN: Contributions of electromigration and electroosmosis to peptide iontophoresis across intact and impaired skin. J Control Release 2005; 108: 319-330.
120. Abla N, Naik A, Guy RH, Kalia YN: Effect of charge and molecular weight on transdermal peptide delivery by iontophoresis. Pharm Res 2005; 22: 2069-2078.
121. Abla N, Naik A, Guy RH, Kalia YN: Topical iontophoresis of valaciclovir hydrochloride improves cutaneous aciclovir delivery. Pharm Res 2006; 23: 1842-1849.
122. Wu X, Landfester K, Musyanovych A, Guy RH: Disposition of charged nanoparticles after their topical application to the skin. Skin Pharmacol Physiol 2010; 23: 117-123.
123. Wu X, Price GJ, Guy RH: Disposition of nanoparticles and an associated lipophilic permeant following topical application to the skin. Mol Pharm 2009; 6: 1441-1448.
124. Campbell CSJ, Contreras-Rojas LR, Delgado-Charro MB, Guy RH: Objective assessment of nanoparticle disposition in mammalian skin after topical exposure. J Control Release 2012; 162: 201-207.
125. Saar BG, Contreras-Rojas LR, Xie XS, Guy RH: Imaging drug delivery to skin with stimulated Raman scattering microscopy. Mol Pharm 2011; 8: 969-975.
126. Nonato LB, Kalia YN, Naik A, Lund CH, Guy RH: The development of skin barrier function in the neonate. J Toxicol Cutan Ocul 2001; 20: 335-366.
127. Sekkat N, Kalia YN, Guy RH: Development of an in vitro model for premature neonatal skin: biophysical characterization using transepidermal water loss. J Pharm Sci 2004; 93: 2936-2940.
128. Tsang M, Guy RH: Effect of aqueous cream BP on human stratum corneum in vivo. Br J Dermatol 2010; 163: 954-958.
129. Kalia YN, Naik A, Garrison J, Guy RH: Iontophoretic drug delivery. Adv Drug Deliv Rev 2004; 56: 619-658.
130. Mehier-Humbert S, Guy RH: Physical methods for gene transfer: improving the kinetics of gene delivery into cells. Adv Drug Deliv Rev 2005; 57: 33-753.
131. Moser K, Kriwet K, Naik A, Kalia YN, Guy RH: Passive skin penetration enhancement and its quantification in vitro. Eur J Pharm Biopharm 2001; 52: 103-112.
132. Naik A, Kalia YN, Guy RH: Transdermal drug delivery: overcoming the skin's barrier function. Pharm Sci Tech Today 2000; 3: 318-326.
133. Guy RH: Current status and future prospects of transdermal drug delivery. Pharm Res 1996; 13: 1765-1769.
134. Cork MJ, Danby SG, Vasilopoulos Y, Hadgraft J, Lane ME, Moustafa M, Guy RH, MacGowan AL, Tazi-Ahnini R, Ward SJ: Epidermal barrier dysfunction in atopic dermatitis. J Invest Dermatol 2009; 129: 1892-1908.